1117 related articles for article (PubMed ID: 23141890)
1. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
2. Progressive familial intrahepatic cholestasis.
Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
Orphanet J Rare Dis; 2009 Jan; 4():1. PubMed ID: 19133130
[TBL] [Abstract][Full Text] [Related]
3. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
4. Progressive familial intrahepatic cholestasis.
Srivastava A
J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
[TBL] [Abstract][Full Text] [Related]
5. DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients.
Shapiro R; Anikster Y; Yardeni T; Korem S; Hartman K; Shamir R; Broide E; Levine A; Bujanover Y; Bercovich D
J Hum Genet; 2010 May; 55(5):308-13. PubMed ID: 20414253
[TBL] [Abstract][Full Text] [Related]
6. Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center.
Giovannoni I; Callea F; Bellacchio E; Torre G; De Ville De Goyet J; Francalanci P
PLoS One; 2015; 10(12):e0145021. PubMed ID: 26678486
[TBL] [Abstract][Full Text] [Related]
7. Progressive familial intrahepatic cholestasis.
Jacquemin E
J Gastroenterol Hepatol; 1999 Jun; 14(6):594-9. PubMed ID: 10385071
[TBL] [Abstract][Full Text] [Related]
8. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
[TBL] [Abstract][Full Text] [Related]
10. [Liver disease associated with hereditary defects of hepatobiliary transporters].
Wendum D
Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
[TBL] [Abstract][Full Text] [Related]
11. Progressive familial intrahepatic cholestasis. Genetic basis and treatment.
Jacquemin E
Clin Liver Dis; 2000 Nov; 4(4):753-63. PubMed ID: 11232355
[TBL] [Abstract][Full Text] [Related]
12. Current and future therapies for inherited cholestatic liver diseases.
van der Woerd WL; Houwen RH; van de Graaf SF
World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
[TBL] [Abstract][Full Text] [Related]
13. Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings.
Morotti RA; Suchy FJ; Magid MS
Semin Liver Dis; 2011 Feb; 31(1):3-10. PubMed ID: 21344347
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
15. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
[TBL] [Abstract][Full Text] [Related]
16. Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis.
El-Guindi MA; Sira MM; Hussein MH; Ehsan NA; Elsheikh NM
Ann Hepatol; 2016; 15(2):222-9. PubMed ID: 26845599
[TBL] [Abstract][Full Text] [Related]
17. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
[TBL] [Abstract][Full Text] [Related]
18. Liver disease associated with canalicular transport defects: current and future therapies.
Stapelbroek JM; van Erpecum KJ; Klomp LW; Houwen RH
J Hepatol; 2010 Feb; 52(2):258-71. PubMed ID: 20034695
[TBL] [Abstract][Full Text] [Related]
19. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
[TBL] [Abstract][Full Text] [Related]
20. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
